Environmental and Occupational Medicine and Epidemiology Program, Department of Environmental Health, Harvard T.H. Chan School of Public Health, 665 Huntington Avenue, Building 1, 14th Floor, Boston, MA, 02115, USA.
Department of Biostatistics, Harvard T.H. Chan School of Public Health, 665 Huntington Avenue, Building 2, 4th Floor, Boston, MA, 02115, USA.
Environ Res. 2023 Sep 15;233:116330. doi: 10.1016/j.envres.2023.116330. Epub 2023 Jun 20.
Epidemiological studies have reported associations of anti-androgenic phthalate metabolite concentrations with later onset of male puberty, but few have assessed associations with progression.
We examined the association of prepubertal urinary phthalate metabolite concentrations with trajectories of pubertal progression among Russian boys.
At enrollment (ages 8-9 years), medical history, dietary, and demographic information were collected. At entry and annually to age 19 years, physical examinations including testicular volume (TV) were performed and spot urines collected. Each boy's prepubertal urine samples were pooled, and 15 phthalate metabolites were quantified by isotope dilution LC-MS/MS at Moscow State University. Metabolites of anti-androgenic parent phthalates were included: butylbenzyl (BBzP), di-n-butyl (DnBP), diisobutyl (DiBP), di(2-ethylhexyl) (DEHP) and diisononyl (DiNP) phthalates. We calculated the molar sums of DEHP, DiNP, and all AAP metabolites. We used group-based trajectory models (GBTMs) to identify subgroups of boys who followed similar pubertal trajectories from ages 8-19 years based on annual TV. We used multinomial and ordinal regression models to evaluate whether prepubertal log-transformed phthalate metabolite concentrations were associated with slower or faster pubertal progression trajectories, adjusting for covariates.
304 boys contributed a total of 752 prepubertal urine samples (median 2, range: 1-6) for creation of individual pools. The median length of follow-up was 10.0 years; 79% of boys were followed beyond age 15. We identified three pubertal progression groups: slower (34%), moderate (43%), and faster (23%) progression. A standard deviation increase in urinary log-monobenzyl phthalate (MBzP) concentrations was associated with higher adjusted odds of being in the slow versus faster pubertal progression trajectory (aOR 1.47, 95% CI 1.06-2.04). None of the other phthalate metabolites were associated with pubertal progression.
On average, boys with higher concentrations of prepubertal urinary MBzP had a slower tempo of pubertal progression, perhaps attributable to the disruption of androgen-dependent biological pathways.
流行病学研究报告了抗雄激素邻苯二甲酸酯代谢物浓度与男性青春期后期发病的关联,但很少有研究评估其与进展的关联。
我们研究了俄罗斯男孩青春期前尿液中邻苯二甲酸酯代谢物浓度与青春期进展轨迹的关系。
在入组时(8-9 岁),收集了病史、饮食和人口统计学信息。在入组时和每年到 19 岁时,进行了体格检查,包括睾丸体积(TV)检查,并采集了尿液样本。将每个男孩的青春期前尿液样本混合,在莫斯科国立大学采用同位素稀释液 LC-MS/MS 定量了 15 种邻苯二甲酸酯代谢物。包括抗雄激素原邻苯二甲酸酯的代谢物:丁基苄基(BBzP)、二正丁基(DnBP)、二异丁基(DiBP)、二(2-乙基己基)(DEHP)和二异壬基(DiNP)邻苯二甲酸酯。我们计算了 DEHP、DiNP 和所有 AAP 代谢物的摩尔总和。我们使用基于群组的轨迹模型(GBTMs),根据每年的 TV,从 8 岁到 19 岁,识别出具有相似青春期轨迹的男孩亚组。我们使用多项和有序回归模型,调整协变量后,评估青春期前 log 转换邻苯二甲酸酯代谢物浓度与青春期进展轨迹较慢或较快的关系。
304 名男孩共提供了 752 份青春期前尿液样本(中位数 2,范围:1-6),用于创建个体样本池。中位随访时间为 10.0 年;79%的男孩随访时间超过 15 岁。我们确定了三个青春期进展组:进展较慢(34%)、进展中等(43%)和进展较快(23%)。尿液中单苄基邻苯二甲酸酯(MBzP)浓度每增加一个标准差,与更快的青春期进展轨迹的调整后比值比(aOR)更高(1.47,95%CI 1.06-2.04)。其他邻苯二甲酸酯代谢物均与青春期进展无关。
平均而言,青春期前尿液中 MBzP 浓度较高的男孩青春期进展速度较慢,这可能归因于雄激素依赖的生物途径受到干扰。